Leap Therapeutics Inc (LPTX) — Cash Flow Quality Index

Latest as of December 2018: -4.76x

Leap Therapeutics Inc (LPTX) has a Cash Flow Quality Index of -4.76x as of December 2018. Operating cash flow of $-7.05 Million is below net income of $1.48 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore LPTX cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-4.76x

Operating CF / Net Income

Operating Cash Flow

$-7.05 Million

USD

Net Income

$1.48 Million

USD

Data as of

Dec 2018

Most recent filing

Annual Cash Flow Quality Index for Leap Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Leap Therapeutics Inc. For live market cap and the full company financial profile, see Leap Therapeutics Inc market cap and net worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.